38 results
Page 2 of 2
6-K
EX-99
rxz9y 3py7h2w9
5 Nov 19
BioLineRx Announces BL-8040 in Combination with KEYTRUDA Shows Clinical Activity in Heavily Pretreated
9:00am
6-K
EX-99
936b7qjt
5 Nov 19
BioLineRx Presents Preclinical Data from Triple Combination
8:00am
6-K
EX-1
0q1bc eth
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
3irkggt
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
6-K
EX-99
b0g34t5aw
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-10.3
44a1ubtdj n2fd0chz
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99.1
pdgigk1 hk52r
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99
yyq5b7vxxq2lqir
7 Aug 18
BioLineRx Announces Positive Results of Lead-in Period
7:00am
20-F/A
EX-4.40
2vgiy
31 May 16
Annual report (foreign) (amended)
12:00am
6-K
EX-99
l1m46etn
16 Dec 13
BioLineRx Announces Promising Initial Phase 2
12:00am
6-K
EX-10.1
pyqdb0g7k9 fhh6
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
F-6
EX-1
ysgndys0oou00mceg
6 Jul 11
Registration for ADRs (foreign)
12:00am
20FR12B
EX-4.17
or63y17bxgltr32z45
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.17
5797t 15o9l
24 Sep 10
Registration statement (foreign)
12:00am